Literature DB >> 3920060

The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptake.

A Janowsky, M M Schweri, P Berger, R Long, P Skolnick, S M Paul.   

Abstract

The specific binding of [3H]threo-(+/-)-methylphenidate to membranes prepared from rat striatum was significantly reduced following either surgical lesions of the medial forebrain bundle or intracerebroventricular administration of 6-hydroxydopamine. The decrease in the density of [3H]threo-(+/-)-methylphenidate binding sites in striatum following chemical or surgical denervation was highly correlated with the decrease in [3H]dopamine uptake. In contrast, intracerebroventricular administration of 5,7-dihydroxytryptamine, AF64A, or chronic parenteral administration of reserpine did not alter either the number of apparent affinity of [3H]threo-(+/-)-methylphenidate binding sites. These data suggest that the specific binding sites for [3H]-threo-(+/-)-methylphenidate in striatum are localized to dopaminergic nerve terminals, and may be associated with the dopamine transport complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920060     DOI: 10.1016/0014-2999(85)90724-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Pharmacokinetics and pharmacodynamics of methylphenidate enantiomers in rats.

Authors:  T Aoyama; H Kotaki; Y Sawada; T Iga
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

2.  High affinity binding of [3H]-tyramine in the central nervous system.

Authors:  A Vaccari
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

3.  Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935.

Authors:  F Mennicken; M Savasta; R Peretti-Renucci; C Feuerstein
Journal:  J Neural Transm Gen Sect       Date:  1992

4.  Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites.

Authors:  T Aoyama; H Kotaki; Y Sawada; T Iga
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.